z-logo
Premium
5‐aminolevulinic acid‐based photodynamic therapy for the treatment of condylomata acuminata in C hinese patients: a meta‐analysis
Author(s) -
Ying Zuolin,
Li Xiaojie,
Dang Hong
Publication year - 2013
Publication title -
photodermatology, photoimmunology and photomedicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.736
H-Index - 60
eISSN - 1600-0781
pISSN - 0905-4383
DOI - 10.1111/phpp.12043
Subject(s) - photodynamic therapy , medicine , adverse effect , erythema , meta analysis , dermatology , hyperpigmentation , randomized controlled trial , confidence interval , edema , surgery , chemistry , organic chemistry
Summary Objective This meta‐analysis was designed to assess the efficacy of topical 5‐aminolaevulinic acid ( ALA ) photodynamic therapy ( PDT ) in C hinese patients with condylomata acuminata ( CA ). Methods Electronic literature databases ( M edline, E mbase, C ochrane L ibrary, C hina N ational K nowledge I nfrastructure, and W anfang database) were searched for relevant randomized controlled trials ( RCTs ) published prior to O ctober 2012. Only RCTs that compared ALA‐PDT to non‐ ALA ‐ PDT for patients with genital condylomata were selected. The outcomes included the recurrence rate and adverse events. The risk ratios ( RRs ) and 95% confidence intervals ( CIs ) were calculated as the ALA‐PDT vs. without ALA‐PDT . Results Twenty RCTs composed of 1903 patients ( ALA‐PDT , n = 1106; non‐ ALA ‐ PDT , n = 797) were included in the meta‐analysis. ALA‐PDT decreased the recurrence rate within 12 week after treatment (vs. without ALA‐PDT , RR : 0.28, 95% CI : 0.22–0.35) and 24 week after treatment (vs. without ALA‐PDT , RR : 0.24, 95% CI : 0.17–0.34) in a fixed‐effect model. The common adverse events related ALA‐PDT included a mild burning and/or stinging sensation, erythema, mild edema, erosion, and hyperpigmentation. Conclusion Local application of ALA‐PDT reduced recurrence rate vs. without ALA‐PDT . The use of ALA ‐ PDT should be considered as a feasible therapy for the treatment of CA .

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom